0001797825-26-000007.txt : 20260828 0001797825-26-000007.hdr.sgml : 20260828 20260828130139 ACCESSION NUMBER: 0001797825-26-000007 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260828 DATE AS OF CHANGE: 20260828 EFFECTIVENESS DATE: 20260828 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aegle Therapeutics Corp CENTRAL INDEX KEY: 0001797825 ORGANIZATION NAME: EIN: 462045726 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-595786 FILM NUMBER: 261337543 BUSINESS ADDRESS: STREET 1: 400 TRADECENTER STREET 2: SUITE 5900 CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: 781-918-8449 MAIL ADDRESS: STREET 1: 400 TRADECENTER STREET 2: SUITE 5900 CITY: WOBURN STATE: MA ZIP: 01801 D 1 primary_doc.xml X0708 D LIVE 0001797825 Aegle Therapeutics Corp 400 TRADECENTER SUITE 5900 WOBURN MA MASSACHUSETTS 01801 781-918-8449 DELAWARE None None Corporation true Shelley Hartman 400 TRADECENTER SUITE 5900 WOBURN MA MASSACHUSETTS 01801 Executive Officer Director Scott Braunstein 400 TRADECENTER SUITE 5900 WOBURN MA MASSACHUSETTS 01801 Director Leon Moulder 400 TRADECENTER SUITE 5900 WOBURN MA MASSACHUSETTS 01801 Director Evangelos Badiavas 400 TRADECENTER SUITE 5900 WOBURN MA MASSACHUSETTS 01801 Director Biotechnology Decline to Disclose 06b false 2026-08-04 false true false 0 2277698 2277698 0 false 17 0 0 0 false Aegle Therapeutics Corp Shelley Hartman Shelley Hartman Chief Executive Officer 2026-08-28